期刊文献+

冠心病合并糖尿病患者血清胱抑素C水平之间相关性 被引量:2

下载PDF
导出
摘要 目的评估冠心病(CAD)合并糖尿病(DM)患者血清胱抑素c(CysC)水平的变化。方法入选51例经冠状动脉造影检查确诊的cAD患者,病例分为两组:单纯cAD组27例,cAD+DM组24例;测定患者的血清Cysc浓度,采用Gensini积分法定量评估冠状动脉病变程度。比较两组患者血清Cysc水平的差异;分析血清Cysc浓度与冠状动脉病变程度的相关性。结果cAD+DM组患者血清Cysc水平和Gensini积分高于单纯cAD组(P〈0.05);Pearson相关分析显示,血清Cysc水平与Gensini积分值呈正相关(r=0.33,P〈0.05)。结论血清Cysc检测有助于反映冠状动脉病变严重程度。CADff并DM患者血清Cysc水平较高。 Objective To assess the serum cystatin C ( Cys C ) levels in coronary artery disease ( CAD ) patients with diabetes mellitus ( DM ) . Methods A total of 51 angiographically diagnosed CAD patients were included in this study. Patients were divideded into two groups: CAD without DM ( n=27 ) and CAD with DM ( n=24 ) . Serum Cys C concentrations were measured. The severity of CAD was calculated using Gensini scoring. Serum Cys C levels in CAD wih DM were compared with those in CAD without DM. The relationship of serum Cys C with the severity of CAD was examined. Results Serum Cys C levels and Gensini score in CAD patients with DM were significiantly higher than those without DM ( P〈0.05 ) . Pearson correlation analysis revealed that the Cys C levels were positively correlated with the CAD Gensini score ( r=0.33, P〈0.05 ) . Conclusion Serum Cys C concentration reflects the severity of CAD. Compared with CAD without DM, CAD with DM have higher levels ofCys C.
出处 《浙江临床医学》 2016年第8期1403-1404,共2页 Zhejiang Clinical Medical Journal
关键词 胱抑素C 冠心病 糖尿病 病变程度 CystatinC Coronary artery disease Diabetesmellitus Severity of disease
  • 相关文献

参考文献11

  • 1Muntner P,Mann D,Winston J,et al.Semm cystatin C and increased coronary heart disease prevalence in US adults without chronic kidney disease. AmJ Cardiol,2008,102(1): 54-57.
  • 2Koc M,Batur MK,Karaarslan,et al.Clinical utility of serum cystatin C in predicting coronary disease. Cardiol J,2010,17(4): 374-380.
  • 3Kiyosue A,Hirata Y,Ando J,et al.Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease. Circ J,2010,74(11): 2441-2447.
  • 4Doganer YC,Aydogan U,Aydogdu A,et at.Relationship of cystatin C with coronary artery disease and its severity.Coron Artery Dis,2013,24(2): 119-126.
  • 5Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease. Am I Cardiol,1983,51(3): 606.
  • 6徐崇利,唐建金,王连生.冠心痛合并糖尿病患者的临床与冠状动脉造影特征分析.当代医学,2007,12(23):12-14.
  • 7Con E,Botey A,Alyvarez L,et al.Serum cystatin C as a new marker for noninvasive estimation of glomemlar filtration rate and as a marker for early renal impairment. Am J Kidney Dis,2000, 36(1): 29-34.
  • 8Shlipak MG,Samak MJ,Katz R,et al.Cystatin C and the risk of death and cardiovascular events among elderly persons.N Engl J Meal,2005,352(20): 2049-2060.
  • 9Ix JH,Shlipak MG,Chertow GM,et al.Associafion of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study.Circulation,2007,115(2): 173-179.
  • 10Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med, 1999, 340(2): 115-126.

同被引文献8

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部